{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T14:00:55Z","timestamp":1784815255073,"version":"3.55.0"},"reference-count":48,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Policy and Practice"],"published-print":{"date-parts":[[2026,12,31]]},"DOI":"10.1080\/20523211.2026.2701918","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T13:05:16Z","timestamp":1784811916000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Cost-utility and budget impact analysis of herpes zoster vaccines in Thai patients with end-stage renal disease"],"prefix":"10.1080","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1590-5182","authenticated-orcid":false,"given":"Nattanichcha","family":"Kulthanachairojana","sequence":"first","affiliation":[{"name":"Burapha University","place":["Chonburi, Thailand"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pattheera","family":"Phothong","sequence":"additional","affiliation":[{"name":"Burapha University","place":["Chonburi, Thailand"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pitch","family":"Promkladphanao","sequence":"additional","affiliation":[{"name":"Burapha University","place":["Chonburi, Thailand"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chollakarn","family":"Singharerg","sequence":"additional","affiliation":[{"name":"Burapha University","place":["Chonburi, Thailand"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jatapat","family":"Hemapanpairoa","sequence":"additional","affiliation":[{"name":"Silpakorn University","place":["Nakhon Pathom, Thailand"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,7,23]]},"reference":[{"key":"e_1_3_6_2_1","unstructured":"Advisory Committee on Immunization Practices. (2024). Evidence to recommendations framework for use of recombinant zoster vaccine in immunocompromised adults aged \u226519 years. Centers for Disease Control and Prevention. Retrieved 8 August from https:\/\/www.cdc.gov\/acip\/evidence-to-recommendations\/recombinant-zoster-immunocompromised-etr.html."},{"issue":"1","key":"e_1_3_6_3_1","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1093\/ckj\/sfy058","article-title":"Mortality risk after herpes zoster infection in end-stage renal disease patients","volume":"12","author":"Ahn J. H.","year":"2019","unstructured":"Ahn, J. H., Waller, J. L., Baer, S. L., Colombo, R. E., Kheda, M. F., Nahman, N. S., Jr., & Turrentine, J. E. (2019). Mortality risk after herpes zoster infection in end-stage renal disease patients. Clinical Kidney Journal, 12(1), 101\u2013105.","journal-title":"Clinical Kidney Journal"},{"key":"e_1_3_6_4_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-016-0355-0"},{"issue":"4","key":"e_1_3_6_5_1","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1365-4632.2010.04715.x","article-title":"Measuring herpes zoster, zoster-associated pain, post-herpetic neuralgia-associated loss of quality of life, and healthcare utilization and costs in Thailand","volume":"50","author":"Aunhachoke K.","year":"2011","unstructured":"Aunhachoke, K., Bussaratid, V., Chirachanakul, P., Chua-Intra, B., Dhitavat, J., Jaisathaporn, K., Kaewkungwal, J., Kampirapap, K., Khuhaprema, T., & Pairayayutakul, K. (2011). Measuring herpes zoster, zoster-associated pain, post-herpetic neuralgia-associated loss of quality of life, and healthcare utilization and costs in Thailand. International Journal of Dermatology, 50(4), 428\u2013435.","journal-title":"International Journal of Dermatology"},{"key":"e_1_3_6_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2013.44"},{"key":"e_1_3_6_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2012.06.012"},{"key":"e_1_3_6_8_1","unstructured":"Centers for Disease Control and Prevention. (2023). Preventing Varicella-Zoster Virus (VZV) transmission from herpes zoster in healthcare settings. Centers for Disease Control and Prevention. Retrieved August 8 from https:\/\/www.cdc.gov\/shingles\/hcp\/infection-control\/index.html."},{"issue":"3","key":"e_1_3_6_9_1","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3747\/pdi.2017.00127","article-title":"Survival analysis and associated factors in Thai patients on peritoneal dialysis under the PD-first policy","volume":"38","author":"Changsirikulchai S.","year":"2018","unstructured":"Changsirikulchai, S., Sriprach, S., Thokanit, N. S., Janma, J., Chuengsaman, P., & Sirivongs, D. (2018). Survival analysis and associated factors in Thai patients on peritoneal dialysis under the PD-first policy. Peritoneal Dialysis International, 38(3), 172\u2013178.","journal-title":"Peritoneal Dialysis International"},{"issue":"16","key":"e_1_3_6_10_1","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1503\/cmaj.091711","article-title":"The impact of herpes zoster and postherpetic neuralgia on health-related quality of life: A prospective study","volume":"182","author":"Drolet M.","year":"2010","unstructured":"Drolet, M., Brisson, M., Schmader, K. E., Levin, M. J., Johnson, R., Oxman, M. N., Patrick, D., Blanchette, C., & Mansi, J. A. (2010). The impact of herpes zoster and postherpetic neuralgia on health-related quality of life: A prospective study. Canadian Medical Association Journal, 182(16), 1731\u20131736.","journal-title":"Canadian Medical Association Journal"},{"key":"e_1_3_6_11_1","doi-asserted-by":"publisher","DOI":"10.1080\/14737167.2020.1693267"},{"key":"e_1_3_6_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nefro.2020.08.016"},{"issue":"1","key":"e_1_3_6_13_1","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1186\/s12913-025-12550-x","article-title":"Cost-effectiveness and public health impact of recombinant zoster vaccine versus no herpes zoster vaccination in selected populations of immunocompromised adults in Canada","volume":"25","author":"George S.","year":"2025","unstructured":"George, S., Carrico, J., Hicks, K. A., Loukov, D., Ng, C., & Curran, D. (2025). Cost-effectiveness and public health impact of recombinant zoster vaccine versus no herpes zoster vaccination in selected populations of immunocompromised adults in Canada. BMC Health Services Research, 25(1), 604.","journal-title":"BMC Health Services Research"},{"key":"e_1_3_6_14_1","unstructured":"Government of C. (2022). Process for incorporating economic evidence into federal vaccine recommendations: National Advisory Committee on Immunization (NACI). https:\/\/www.nitag-resource.org\/sites\/default\/files\/2022-08\/Process%20for%20incorporating%20economic%20evidence%20into%20federal%20vaccine%20recommendations_%20National%20Advisory%20Committee%20on%20Immunization%20%28NACI%29%20-%20Canada.ca_.pdf."},{"key":"e_1_3_6_15_1","unstructured":"Health Intervention and Technology Assessment Program (HITAP). (2019). Cost Analysis of health promotion and disease prevention services (Fiscal year 2019). Health Intervention and Technology Assessment Program; supported by NHSO (Thailand). Retrieved August 8 from https:\/\/www.hitap.net\/wp-content\/uploads\/2020\/06\/full-report-Cost-PP.pdf."},{"key":"e_1_3_6_16_1","volume-title":"Guideline for health technology assessment in Thailand (2021)","author":"Health Intervention and Technology Assessment Program (HITAP)","year":"2021","unstructured":"Health Intervention and Technology Assessment Program (HITAP). (2021). Guideline for health technology assessment in Thailand (2021). Ministry of Public Health."},{"issue":"2","key":"e_1_3_6_17_1","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.3346\/jkms.2019.34.e1","article-title":"Recurrence rate of herpes zoster and its risk factors: A population-based cohort study","volume":"34","author":"Kim Y. J.","year":"2018","unstructured":"Kim, Y. J., Lee, C. N., Lee, M. S., Lee, J. H., Lee, J. Y., Han, K., & Park, Y. M. (2018). Recurrence rate of herpes zoster and its risk factors: A population-based cohort study. Journal of Korean Medical Science, 34(2), e1.","journal-title":"Journal of Korean Medical Science"},{"key":"e_1_3_6_18_1","doi-asserted-by":"crossref","first-page":"e943808","DOI":"10.12659\/MSM.943808","article-title":"Prevalence and management of chronic pain, including neuropathic pain, in dialysis patients with end-stage renal disease","volume":"30","author":"Kitala-Ta\u0144ska K.","year":"2024","unstructured":"Kitala-Ta\u0144ska, K., Kania-Zimnicka, E., Ta\u0144ski, D., Kwella, N., Stomp\u00f3r, T., & Stomp\u00f3r, M. (2024). Prevalence and management of chronic pain, including neuropathic pain, in dialysis patients with end-stage renal disease. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research, 30, e943808\u2013943801.","journal-title":"Medical Science Monitor: International Medical Journal of Experimental and Clinical Research"},{"key":"e_1_3_6_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vhri.2025.101119"},{"issue":"1","key":"e_1_3_6_20_1","first-page":"gfae069-0524-24","article-title":"# 2434 literature review on the burden of herpes zoster in patients with kidney disease \u2013 a need for earlier prevention","volume":"39","author":"Kumar D.","year":"2024","unstructured":"Kumar, D., Jorga, A., Yun, H., & Williams, C. (2024). # 2434 literature review on the burden of herpes zoster in patients with kidney disease \u2013 a need for earlier prevention. Nephrology Dialysis Transplantation, 39(Supplement_1), gfae069-0524-2434.","journal-title":"Nephrology Dialysis Transplantation"},{"key":"e_1_3_6_21_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2011.10.049"},{"key":"e_1_3_6_22_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1501184"},{"key":"e_1_3_6_23_1","doi-asserted-by":"publisher","DOI":"10.7326\/M15-0093"},{"key":"e_1_3_6_24_1","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens13070596"},{"key":"e_1_3_6_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2021.01.051"},{"key":"e_1_3_6_26_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0313889"},{"issue":"7","key":"e_1_3_6_27_1","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1007\/s40620-023-01690-0","article-title":"Recombinant varicella zoster vaccine in haemodialysis facilities: Adherence and safety","volume":"36","author":"Martino F. K.","year":"2023","unstructured":"Martino, F. K., Pini, S., Scaparrotta, G., Schirinzi, M., Gnappi, M., Fragasso, A., Zanella, R., Naso, E., De Giorgi, M. L., & Carraro, G. (2023). Recombinant varicella zoster vaccine in haemodialysis facilities: Adherence and safety. Journal of Nephrology, 36(7), 2155\u20132158.","journal-title":"Journal of Nephrology"},{"key":"e_1_3_6_28_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6906a4"},{"key":"e_1_3_6_29_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2018.1456598"},{"issue":"1","key":"e_1_3_6_30_1","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1186\/s12879-020-05648-6","article-title":"Herpes zoster risk and burden of disease in immunocompromised populations: A population-based study using health system integrated databases, 2009\u20132014","volume":"20","author":"Mu\u00f1oz-Quiles C.","year":"2020","unstructured":"Mu\u00f1oz-Quiles, C., L\u00f3pez-Lacort, M., D\u00edez-Domingo, J., & Orrico-S\u00e1nchez, A. (2020). Herpes zoster risk and burden of disease in immunocompromised populations: A population-based study using health system integrated databases, 2009\u20132014. BMC Infectious Diseases, 20(1), 905.","journal-title":"BMC Infectious Diseases"},{"issue":"2","key":"e_1_3_6_31_1","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/aje\/kwac170","article-title":"Active postlicensure safety surveillance for recombinant zoster vaccine using electronic health record data","volume":"192","author":"Nelson J. C.","year":"2023","unstructured":"Nelson, J. C., Ulloa-P\u00e9rez, E., Yu, O., Cook, A. J., Jackson, M. L., Belongia, E. A., Daley, M. F., Harpaz, R., Kharbanda, E. O., & Klein, N. P. (2023). Active postlicensure safety surveillance for recombinant zoster vaccine using electronic health record data. American Journal of Epidemiology, 192(2), 205\u2013216.","journal-title":"American Journal of Epidemiology"},{"key":"e_1_3_6_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2022.100548"},{"key":"e_1_3_6_33_1","unstructured":"Public Health E. (2013). Code of practice for the Joint Committee on Vaccination and Immunisation (JCVI). https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/224864\/JCVI_Code_of_Practice_revision_2013_-_final.pdf."},{"issue":"4","key":"e_1_3_6_34_1","first-page":"88","article-title":"Quality of life and utilities of end stage renal disease patients undergoing dialysis","volume":"14","author":"Rattanachotphanit T.","year":"2018","unstructured":"Rattanachotphanit, T., Waleekhachonloet, O., Chanasopon, S., Ausornsagiam, W., Kanjanasilp, J., & Suwattanasilp, A. (2018). Quality of life and utilities of end stage renal disease patients undergoing dialysis. Isan J Pharm Sci, 14(4), 88\u201398.","journal-title":"Isan J Pharm Sci"},{"issue":"7","key":"e_1_3_6_35_1","doi-asserted-by":"crossref","first-page":"A645","DOI":"10.1016\/j.jval.2012.08.255","article-title":"PRM3 standard cost list for economic evaluation in Thailand","volume":"15","author":"Riewpaiboon A.","year":"2012","unstructured":"Riewpaiboon, A. (2012). PRM3 standard cost list for economic evaluation in Thailand. Value in Health, 15(7), A645.","journal-title":"Value in Health"},{"issue":"10","key":"e_1_3_6_36_1","first-page":"656","article-title":"Herpes zoster and postherpetic neuralgia: Prevention and management","volume":"96","author":"Saguil A.","year":"2017","unstructured":"Saguil, A., Kane, S., Mercado, M., & Lauters, R. (2017). Herpes zoster and postherpetic neuralgia: Prevention and management. American Family Physician, 96(10), 656\u2013663.","journal-title":"American Family Physician"},{"key":"e_1_3_6_37_1","doi-asserted-by":"publisher","DOI":"10.1007\/s41669-023-00438-7"},{"issue":"5","key":"e_1_3_6_38_1","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/1744-9987.70056","article-title":"Thailand renal replacement therapy registry 2023: Epidemiological insights into dialysis trends and challenges","volume":"29","author":"Satirapoj B.","year":"2025","unstructured":"Satirapoj, B., Tantiyavarong, P., Thimachai, P., Chuasuwan, A., Lumpaopong, A., Kanjanabuch, T., & Ophascharoensuk, V. (2025). Thailand renal replacement therapy registry 2023: Epidemiological insights into dialysis trends and challenges. Therapeutic Apheresis and Dialysis, 29(5), 721\u2013729.","journal-title":"Therapeutic Apheresis and Dialysis"},{"key":"e_1_3_6_39_1","doi-asserted-by":"publisher","DOI":"10.1177\/20494637211073050"},{"issue":"1","key":"e_1_3_6_40_1","first-page":"117","article-title":"Implementation of personal vaccination record (PVR) to increase completeness and adherence of multi-dose adult vaccination: A retrospective study at the wellness center, Burapha University Hospital","volume":"13","author":"Suranartwatchawong S. S.","year":"2022","unstructured":"Suranartwatchawong, S. S. (2022). Implementation of personal vaccination record (PVR) to increase completeness and adherence of multi-dose adult vaccination: A retrospective study at the wellness center, Burapha University Hospital. Journal of Nakornping Hospital, 13(1), 117\u2013127.","journal-title":"Journal of Nakornping Hospital"},{"key":"e_1_3_6_41_1","unstructured":"Thai CaseMix Centre Health Systems Research Institute. (2024). Thai Diagnosis Related Group (TDRG) version 6.3: Grouping manual (Vols. 1\u20132 with appendices F1 and F2). Thai CaseMix Centre. Retrieved August 8 from https:\/\/www.tcmc.or.th\/download-tcmc."},{"key":"e_1_3_6_42_1","unstructured":"Thai Red Cross AIDS and Infectious Diseases Research Centre (Anonymous Clinic). (2025). Vaccination service. Retrieved August 8 from https:\/\/th.aidsid.or.th\/vaccination-service\/."},{"key":"e_1_3_6_43_1","doi-asserted-by":"crossref","first-page":"100227","DOI":"10.1016\/j.jcte.2020.100227","article-title":"Trends in influenza and pneumococcal vaccine coverage in Thai patients with type 2 diabetes mellitus 2010\u20132018: Experience from a tertiary diabetes center in Bangkok","volume":"20","author":"Thewjitcharoen Y.","year":"2020","unstructured":"Thewjitcharoen, Y., Butadej, S., Malidaeng, A., Yenseung, N., Nakasatien, S., Lekpittaya, N., Kittipoom, W., Krittiyawong, S., & Himathongkam, T. (2020). Trends in influenza and pneumococcal vaccine coverage in Thai patients with type 2 diabetes mellitus 2010\u20132018: Experience from a tertiary diabetes center in Bangkok. Journal of Clinical & Translational Endocrinology, 20, 100227.","journal-title":"Journal of Clinical & Translational Endocrinology"},{"key":"e_1_3_6_44_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ930"},{"key":"e_1_3_6_45_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines13030250"},{"key":"e_1_3_6_46_1","unstructured":"World Health O. (2024). Strategic Advisory Group of Experts (SAGE) on immunization: 2024 meeting highlights. https:\/\/cdn.who.int\/media\/docs\/default-source\/immunization\/sage\/2024\/september\/sage-sept_2024-highlights_final.pdf."},{"key":"e_1_3_6_47_1","doi-asserted-by":"crossref","first-page":"978203","DOI":"10.3389\/fimmu.2022.978203","article-title":"Efficacy, effectiveness, and safety of herpes zoster vaccine in the immunocompetent and immunocompromised subjects: A systematic review and network meta-analysis","volume":"13","author":"Xia Y.","year":"2022","unstructured":"Xia, Y., Zhang, X., Zhang, L., & Fu, C. (2022). Efficacy, effectiveness, and safety of herpes zoster vaccine in the immunocompetent and immunocompromised subjects: A systematic review and network meta-analysis. Frontiers in Immunology, 13, 978203.","journal-title":"Frontiers in Immunology"},{"key":"e_1_3_6_48_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-020528"},{"key":"e_1_3_6_49_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3182a3516e"}],"container-title":["Journal of Pharmaceutical Policy and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/20523211.2026.2701918","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/20523211.2026.2701918","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/20523211.2026.2701918","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T13:05:24Z","timestamp":1784811924000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/20523211.2026.2701918"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,23]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12,31]]}},"alternative-id":["10.1080\/20523211.2026.2701918"],"URL":"https:\/\/doi.org\/10.1080\/20523211.2026.2701918","relation":{},"ISSN":["2052-3211"],"issn-type":[{"value":"2052-3211","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,23]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=jppp20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=jppp20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-09-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-05","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-23","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2701918"}}